GlassScriptPhysician profile
Madelyn Palmer
NPI 1417928649
$7,464.53
in general payments reported to CMS, 2019-2025
68 companies · $892 in 2025
The $892 reported for 2025 was more than what 84% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $781 · 2020: $623 · 2021: $1,096 · 2022: $1,131 · 2023: $1,525 · 2024: $1,417 · 2025: $892.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,834.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,833.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,514.84 | 2020-2025 | |
| Pfizer INC. | $539.77 | 2022-2025 | |
| Amgen INC. | $497.39 | 2019-2025 | Evenity, Prolia, Repatha |
| Allergan, INC. | $333.60 | 2019-2020 | |
| Novo Nordisk INC | $319.11 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $284.12 | 2019-2025 | Airsupra, Farxiga |
| Janssen Pharmaceuticals, INC | $225.00 | 2019-2024 | Spravato, Xarelto |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $218.26 | 2020-2025 | Xifaxan, Trulance |
| Astellas Pharma US INC | $216.36 | 2019-2024 | Veozah |
| Boehringer Ingelheim Pharmaceuticals, INC. | $209.10 | 2019-2024 | |
| Boston Scientific Corporation | $170.71 | 2022-2024 | Wavewriter Alpha Prime 16 |
| Glaxosmithkline, LLC. | $163.76 | 2019-2023 | Arexvy, Shingrix |
| Biohaven Pharmaceutical Holding Company LTD. | $162.33 | 2022 | |
| Novartis Pharmaceuticals Corporation | $148.44 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $139.54 | 2019-2025 | Gardasil 9, Capvaxive, Belsomra |
Show all 68 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $124.87 | 2020-2025 | Strensiq |
| Lilly USA, LLC | $120.05 | 2022-2025 | Mounjaro, Zepbound, Kisunla |
| Exact Sciences Corporation | $114.69 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Eisai INC. | $107.76 | 2020-2023 | |
| Otsuka America Pharmaceutical, INC. | $102.49 | 2021-2024 | Rexulti, Nuedexta |
| Esperion Therapeutics, INC. | $92.46 | 2020-2024 | Nexletol |
| Paratek Pharmaceuticals, INC. | $80.42 | 2021-2022 | |
| Axsome Therapeutics, INC. | $74.39 | 2022-2024 | Sunosi |
| Horizon Therapeutics Plc | $69.95 | 2019-2023 | Krystexxa |
| Amarin Pharma, INC. | $69.68 | 2019-2021 | |
| Idorsia Pharmaceuticals US INC | $68.24 | 2023-2024 | Quviviq |
| Teva Pharmaceuticals USA, INC. | $65.04 | 2019-2023 | Airduo Digihaler |
| Nestle Healthcare Nutrition INC. | $60.91 | 2021-2022 | |
| Abbott Laboratories | $58.47 | 2024-2025 | Freestyle Libre 3, Eterna |
| Bayer Healthcare Pharmaceuticals INC. | $58.39 | 2025 | |
| Sunovion Pharmaceuticals INC. | $57.25 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $55.87 | 2023-2025 | Gemtesa |
| Harmony Biosciences LLC | $53.41 | 2023-2024 | Wakix |
| Radius Health, INC. | $53.09 | 2023 | Tymlos |
| Edwards Lifesciences Corporation | $43.19 | 2022-2025 | Sapien 3 Ultra Resilia |
| E.R. Squibb & Sons, L.L.C. | $41.05 | 2021-2023 | Eliquis |
| Nevro Corp. | $40.31 | 2022-2023 | Senza |
| Biohaven Pharmaceuticals, INC. | $40.02 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $37.15 | 2020-2021 | |
| Strongbridge US INC. | $35.89 | 2019 | |
| Ibsa Pharma INC. | $35.43 | 2021-2025 | Licart, Tirosint, Flector |
| Vanda Pharmaceuticals INC. | $32.75 | 2025 | Fanapt |
| Adlon Therapeutics L.P. | $30.05 | 2020-2021 | |
| Lucid Diagnostics INC. | $29.92 | 2022 | |
| Ironwood Pharmaceuticals, INC | $28.00 | 2020 | |
| Seqirus USA INC | $27.74 | 2021-2022 | |
| Sanofi Pasteur INC. | $27.52 | 2019 | |
| Avion Pharmaceuticals | $27.20 | 2022 | |
| Sanofi-Aventis U.S. LLC | $27.19 | 2024 | |
| Inogen, INC. | $25.00 | 2023 | Inogen |
| Lundbeck LLC | $24.49 | 2023 | Rexulti |
| Phadia US INC. | $23.69 | 2025 | Immunocap |
| Ethicon US, LLC | $21.81 | 2019 | |
| Bausch Health US, LLC | $19.83 | 2019 | |
| Abiomed | $19.02 | 2025 | |
| Jazz Pharmaceuticals INC. | $18.66 | 2021 | |
| Daiichi Sankyo INC. | $18.41 | 2024 | Injectafer |
| Kowa Pharmaceuticals America, INC. | $16.73 | 2022 | |
| Scilex Pharmaceuticals INC. | $16.30 | 2023 | Ztlido |
| Alkermes, INC. | $15.76 | 2022 | |
| Acella Pharmaceuticals, LLC | $15.19 | 2025 | NP Thyroid 60 |
| Biotronik INC. | $14.84 | 2022 | |
| Aimmune Therapeutics, INC. | $14.74 | 2024 | |
| Shire North American Group INC | $14.54 | 2019 | |
| Therapeuticsmd, INC. | $14.45 | 2019 | |
| Antares Pharma, INC. | $13.81 | 2019 | |
| Tactile Systems Technology INC | $12.83 | 2023 | Flexitouch Plus, Entre Plus |
| Si-Bone, INC. | $11.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madelyn Palmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.